Ask AI
ProCE Banner Activity

Charting the Course Podcast: Antivirals for Refractory CMV Infections

Podcast Episodes

Stream now to learn to appropriately modify antiviral therapy in solid organ transplant recipients with treatment-refractory cytomegalovirus (CMV) infections from expert faculty, Atul Humar, MD, FRCP (C).

Released: August 29, 2025

Share

Provided by

Provided by Clinical Care Options (CCO) in partnership with ProCE

ProCE Banner

Supporters

Supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc.

Takeda Pharmaceuticals U.S.A., Inc.

Partners

ProCE, LLC

ProCE Banner

Disclosure

Primary Author

Atul Humar, MD, FRCP (C): consultant/advisor/speaker: Eurofins, Merck, Takeda; researcher: Qiagen.